American Cryostem (CRYO) Inventory Turnover Ratio, from third quarter 2022 to third quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
American Cryostem Corporation  (CRYO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

American Cryostem Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

American Cryostem Corporation inventory turnover ratio, the American Cryostem Corporation's ability to sell and replace its inventory in the third quarter 2022, sequentially increased to 1.33 in the third quarter 2022, yet the ratio remained below the average, as CRYO's market remain challenging.Average inventory processing period, for the American Cryostem in Jun 30 2022 quarter, has decreased to 274 days, compare to 338 days, in the Mar 31 2022 quarter.

Within Healthcare sector 342 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1904 in the second quarter 2022, to 1911.

CRYO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is American Cryostem Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRYO Inventory Turnover Ratio (Jun 30 2022)
III. Quarter		 (Mar 31 2022)
II. Quarter		 (Dec 31 2021)
I. Quarter		 (Sep 30 2021)
IV. Quarter		 (Jun 30 2021)
III. Quarter
Y / Y Inventory Growth -15.83 % -9.82 % 7.14 % -12.09 % -35 %
Y / Y Cost of Sales Growth 696.83 % -37.04 % 471.4 % -95.68 % -86.68 %
Inventory Turnover Ratio (TTM) 1.33 1.08 1.13 0.44 1.39
CRYO's Total Ranking # 1911 # 1904 # 1925 # 1853 #
Average inventory processing period 274 339 323 827 262
Seq. Inventory Growth 11.8 % -18.82 % 33.42 % -30.49 % 19.78 %
Seq. Cost of Sales Growth 58.57 % -84.02 % 1830.6 % 62.83 % -87.47 %




Inventory Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 17
Healthcare Sector # 343
Overall Market # 1911

Inventory Turnover Ratio Statistics
High Average Low
20.68 6.41 0.44
(Sep 30 2017)   (Sep 30 2021)



CRYO Company Profile >> Back to CRYO Efficiency Comparisons >> Compare CRYO Inventory Turnover Ratio to its Competitors

Financial Statements
American Cryostem's Inventories $ 0 Millions Visit CRYO's Balance sheet
American Cryostem's Cost of Revenues TTM $ 0 Millions Visit CRYO's Income Statement
What are CRYO's Sales? Visit CRYO's Sales by Segment

Other Inventory Turnover Ratios
American Cryostem's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Healthcare Facilities Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CRYO's Inventory Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CRYO's Competitors
Inventory Turnover Ratio for CRYO's Suppliers
Inventory Turnover Ratio for CRYO's Customers

You may also want to know
CRYO's Sales Growth Rates CRYO's Pe Price to earnings ratio CRYO's Receivables Turnover Ratio CRYO's Stock Quote
CRYO's Net Income Growth Rates CRYO's Ps Price to Sales ratio CRYO's Sales per Employee CRYO's Asset Turnover Ratio
CRYO's Net Margin CRYO's Pb Price to Book ratio CRYO's Financial Strength Ratios CRYO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2022 Inventories at quarter ending Jun 30 2022
Mallinckrodt Plc  3.50 $ 1,259.700  Millions$ 360  Millions
Epizyme Inc.  3.49 $ 12.959  Millions$ 4  Millions
Abbott Laboratories  3.47 $ 19,109.000  Millions$ 5,502  Millions
Mimedx Group Inc   3.47 $ 42.641  Millions$ 12  Millions
Iridex Corp  3.45 $ 30.734  Millions$ 9  Millions
Catalyst Pharmaceuticals Inc   3.44 $ 26.191  Millions$ 8  Millions
Sonoma Pharmaceuticals Inc   3.42 $ 8.941  Millions$ 3  Millions
Dentsply Sirona Inc   3.39 $ 1,860.000  Millions$ 549  Millions
Agilent Technologies inc   3.38 $ 3,049.000  Millions$ 902  Millions
Illumina Inc   3.36 $ 1,523.000  Millions$ 454  Millions
Dynatronics Corporation  3.35 $ 33.665  Millions$ 10  Millions
American Bio Medica Corporation  3.32 $ 1.397  Millions$ 0  Millions
Staar Surgical Co  3.31 $ 58.226  Millions$ 18  Millions
Alimera Sciences Inc  3.30 $ 7.501  Millions$ 2  Millions
Zeo Scientifix Inc   3.27 $ 0.592  Millions$ 0  Millions
Urogen Pharma Ltd   3.25 $ 6.204  Millions$ 2  Millions
Inspiremd Inc   3.24 $ 4.065  Millions$ 1  Millions
Avita Medical Inc   3.22 $ 6.309  Millions$ 2  Millions
Waters Corporation  3.16 $ 1,215.023  Millions$ 384  Millions
Rayont Inc   3.15 $ 1.457  Millions$ 0  Millions
Immucell Corporation  3.09 $ 10.665  Millions$ 3  Millions
Aytu Biopharma Inc  3.08 $ 44.386  Millions$ 14  Millions
Cue Health Inc   3.08 $ 331.491  Millions$ 108  Millions
Tactile Systems Technology Inc   3.05 $ 62.985  Millions$ 21  Millions
Angiodynamics Inc   3.05 $ 150.487  Millions$ 49  Millions
Strata Skin Sciences Inc  3.03 $ 12.417  Millions$ 4  Millions
Lannett Company Inc  3.03 $ 309.342  Millions$ 102  Millions
Intuitive Surgical Inc   2.98 $ 1,898.600  Millions$ 637  Millions
Biolife Solutions Inc   2.96 $ 90.013  Millions$ 30  Millions
Sonendo Inc   2.94 $ 28.025  Millions$ 10  Millions

Date modified: 2026-09-08T15:10:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.